TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mangoceuticals, Inc. ( (MGRX) ) has shared an announcement.
On June 2 and June 9, 2025, Mangoceuticals, Inc. saw significant warrant exercises and stock conversions, resulting in the issuance of new common stock shares. Abri Advisors Ltd., Clover Crest Bahamas Ltd., and Indigo Capital LP exercised warrants, while a Series B Convertible Preferred Stock conversion also took place, all under exemptions from registration. Additionally, on June 5, 2025, the company executed an Advance Notice under its Equity Purchase Agreement with Platinum Point Capital, selling 100,000 shares for $193,190, further strengthening its financial position.
More about Mangoceuticals, Inc.
Average Trading Volume: 298,091
Technical Sentiment Signal: Sell
Current Market Cap: $22.51M
See more insights into MGRX stock on TipRanks’ Stock Analysis page.